3rd Annual Atlanta Precision Oncology Symposium
ADCs & Targeted Therapies for Advanced TNBC: Can Sacituzumab Govitecan Improve PFS? Should We Use Tala vs. Chemo for BRCA1/2 Patients? Is Olaparib Mono a New SoC?
Login to view comments.
Click here to Login